Check-Cap Ltd. (CHEK)

IL — Healthcare Sector
Peers: FONR  BNR  BDSX  JAGX  FRSX  INUV 

Automate Your Wheel Strategy on CHEK

With Tiblio's Option Bot, you can configure your own wheel strategy including CHEK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol CHEK
  • Rev/Share 0.0
  • Book/Share 2.9362
  • PB 0.252
  • Debt/Equity 0.0
  • CurrentRatio 19.6648
  • ROIC -0.6348

 

  • MktCap 4329266.0
  • FreeCF/Share -0.6061
  • PFCF -1.2209
  • PE -0.4342
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -0.5153

 

  • Rating
  • Score
  • Recommendation
  • P/E Score
  • DCF Score
  • P/B Score
  • D/E Score

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction
CHEK, MEDIF
Published: May 08, 2025 by: PRNewsWire
Sentiment: Neutral

Believes Board Change is Urgently Needed: Under the Current Board and Management, MediPharm Stock Price is Down More Than 99%, Costing Shareholders Nearly $1 Billion MediPharm's Board Cannot be Trusted to Create Shareholder Value or Oversee Management! Company Leadership Lacks Any Credible Strategic Plan and Has Made Numerous Reckless Acquisitions While Rewarding Themselves with Excessive Compensation for Repeated Failures Apollo's Nominees Bring Significant Turnaround, M&A, and Operational Experience in Cannabis and Adjacent Industries, and Will Execute Plan to Restore Value for ALL MediPharm Shareholders Urges MediPharm Shareholders to Vote for Wholesale Change at Annual Meeting Sends Letter to MediPharm Shareholders …

Read More
image for news Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction

About Check-Cap Ltd. (CHEK)

  • IPO Date 2015-03-04
  • Website https://www.check-cap.com
  • Industry Medical - Diagnostics & Research
  • CEO Yoav Kimchy
  • Employees 85

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.